Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

CREO.L

SELL

Creo Medical Group PLC · Healthcare · United Kingdom · $87M · Avg Vol: $120K/d

31
StockRank
Get insider-trade alerts
Q
26
V
28
M
68
P/E (TTM)
—
ROE
-76.5%
D/E
0.1x
Dividend %
—
Dir. Trades · 180d
None →
Buybacks · 180d
None →

COMPANY DESCRIPTION

Creo Medical Group PLC is a medical technology company that develops and commercializes minimally invasive surgical devices utilizing its proprietary CROMA advanced energy platform. The patented technology combines bipolar radiofrequency and microwave energy to enable precise tissue resection and coagulation. Creo is a high-growth innovator transforming therapeutic endoscopy and laparoscopic surgery globally.

FINANCIAL SUMMARY (USD)

Year20212022202320242025CAGRTTM
Revenue33.2M35.9M5.3M5.3M7.9M-30.1%—
EPS-0.19-0.07-0.09-0.110.01—-0.05
Shares187.7M485.8M361.3M412.1M412.5M+119.8%485.8M
Debt13.9M15.4M11.0M5.8M5.4M-21.1%5.4M
Equity96.8M65.1M78.9M56.0M66.0M-9.1%—
Op CF-34.3M-32.9M-28.5M-29.3M-25.2M—-9.2M
Inv CF-10.4M-7.9M-24.2M20.2M26.3M——
Fin CF42.2M0.5M39.3M21.4M-0.9M——
Loading 1Y...
PRICE (1Y)-2.4%
0.180.180.190.190.19Jun 15Jul 6Jul 24
SMA 50SMA 200
Close
$0.1798
RSI (14)
0.0
52W High
$0.2442
From 52W High
0.7%

SCORE BREAKDOWN

Quality
26
ROIC
-64.3%11.3
ROE
-76.5%11.9
GP/Assets
0.3%12.1
Op. Margin
-4571.3%3.9
FCF/Assets
-10.4%28.8
Piotroski
550.0
Int. Cover
-50.0x6.3
D/E Ratio
0.08x66.0
Current Ratio
4.65x68.4
Value
28
P/E (TTM)
—N/A
EV/EBITDA
-0.8x25.0
P/FCF
—N/A
P/B
2.3x54.8
P/S
302.0x5.0
Div Yield
—N/A
Momentum
68
52W High %
74%60.3
RS 6M
7%78.6
SMA 50/200
1.09x80.4
EPS Rev 4W
+8.5%95.3
EPS Rev 12W
—N/A
EPS Improve
+69%63.4
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$87M
P/E (Forward)
-11.2x
Gross Margin
100.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of CREO.L are excluded.

TickerCompanyMkt CapStockRankSignal
CREO.LCreo Medical Group PLC(you)$87M31SELL
EKF.LEKF Diagnostics Holdings plc$153M79BUY
IHC.LInspiration Healthcare Group plc$27M69BUY
NIOX.LNIOX Group Plc$319M87STRONG BUY
STX.LShield Therapeutics plc$86M21SELL
HVO.LhVIVO plc$63M36HOLD
POLB.LPoolbeg Pharma PLC$63M24SELL
4BB.L4basebio PLC$110M11STRONG SELL
HEMO.LHemogenyx Pharmaceuticals Plc$70M9STRONG SELL
OKYOOKYO Pharma Limited$81M6STRONG SELL

Peer medians: ROE 0.2% · P/E 24.7x · Gross margin 55.5%

Creo Medical Group PLC (CREO.L) — Stock Score Summary

Creo Medical Group PLC (CREO.L) has a MoatMap StockRank of 31/100 based on Quality (26/100), Value (28/100), and Momentum (68/100) factor scores. The current signal is SELL.

Creo Medical Group PLC is a medical technology company that develops and commercializes minimally invasive surgical devices utilizing its proprietary CROMA advanced energy platform. The patented technology combines bipolar radiofrequency and microwave energy to enable precise tissue resection and coagulation. Creo is a high-growth innovator transforming therapeutic endoscopy and laparoscopic surgery globally.

Key Financial Metrics

Price$0.18
Market Cap$87M
P/E (Forward)-11.19
Price/Book2.29
Return on Equity-76.5%
Return on Invested Capital-64.3%
Debt/Equity0.08x
Gross Margin100.0%
Operating Margin-4571.3%
Free Cash Flow$-9M

Creo Medical Group PLC operates in the Medical Devices industry, part of the Healthcare sector (United Kingdom).

Frequently Asked Questions

What is Creo Medical Group PLC’s (CREO.L) StockRank?
MoatMap’s StockRank for Creo Medical Group PLC (CREO.L) is 31/100, with a Sell signal. It is a composite of Quality (26), Value (28), and Momentum (68) factor ranks across MoatMap’s 20,000+ stock universe.
Does Creo Medical Group PLC have an economic moat?
Creo Medical Group PLC (CREO.L) has a Quality factor score of 26/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Creo Medical Group PLC a buy, hold, or sell?
MoatMap’s current signal for Creo Medical Group PLC (CREO.L) is Sell, based on a StockRank of 31/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Creo Medical Group PLC in?
Creo Medical Group PLC (CREO.L) operates in the Healthcare sector, specifically the Medical Devices industry (United Kingdom).
Browse all ranked stocksCREO.L deep dive reportAI ChampionsHow we score stocksSense-check another stock